Related Experiment Video
Updated: Sep 29, 2025
11:32
Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
Published on: August 6, 2021
2.8K
[Succinate dehydrogenase in cancer].
1Université de Paris, PARCC, Inserm UMR970, Équipe labellisée par la Ligue contre le cancer, Paris, France.
Medecine Sciences : M/S
|March 25, 2022
Summary
Succinate dehydrogenase (SDH) mutations are linked to rare tumors and decreased SDH activity in common cancers. Inactivation of SDH leads to succinate buildup, promoting cancer development through epigenetic changes.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Succinate dehydrogenase (SDH) is a key mitochondrial enzyme in cellular respiration.
- SDH mutations predispose individuals to specific tumors like pheochromocytomas and paragangliomas.
- Reduced SDH activity is observed in common cancers, independent of genetic mutations.
Purpose of the Study:
- To explore the role of SDH in oncogenesis.
- To understand the consequences of SDH inactivation in cancer development.
- To identify potential diagnostic and therapeutic strategies targeting SDH-related pathways.
Main Methods:
- Analysis of SDH enzyme activity in various cancer types.
- Investigation of succinate accumulation and its downstream effects.
- Evaluation of epigenetic alterations associated with SDH dysfunction.
Main Results:
- SDH inactivation leads to excessive succinate production.
- Succinate acts as an oncometabolite, inducing pseudohypoxic conditions.
- SDH dysfunction drives significant epigenetic rearrangements contributing to oncogenesis.
Conclusions:
- Understanding SDH's role in cancer provides insights into tumorigenesis.
- Targeting SDH-related pathways offers potential for novel cancer diagnostics.
- Therapeutic strategies focused on SDH dysfunction may benefit cancer patients.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:20Sulfur Assimilation
98
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
98
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K